IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — OBIO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents20.4728.3742.0118.7518.3525.6123.7123.3219.0816.4118.700.741.311.421.781.911.95
Short-term Investments89.4966.0353.8115.1831.5441.3241.4751.6989.41101.30108.44------------
Accounts Receivable0.050.080.050.080.090.120.080.070.090.170.08------------
Inventory0.250.280.370.190.140.230.070.120.140.180.23------------
Total Current Assets111.2496.2197.7735.8851.9068.5566.4876.43110.19119.59129.880.871.341.491.862.022.09
Property, Plant & Equipment2.051.851.601.371.411.251.241.311.361.411.45------------
Total Non-current Assets*4.464.457.046.947.156.775.906.206.176.296.4067.78160.24160.04160.02160.01160.01
Total Assets115.70100.66104.8142.8359.0575.3272.3882.63116.36125.88136.2868.65161.58161.53161.88162.03162.10
Accounts Payable6.136.318.475.315.564.726.273.353.153.012.770.280.170.100.000.020.03
Total Current Liabilities13.4713.6920.6617.0615.4916.2214.5010.4221.4711.8612.061.441.100.310.140.190.17
Long-term Debt--15.0015.0015.0015.00------10.0010.00--------------
Total Non-current Liabilities*72.8136.0040.4125.4726.7112.8813.7515.0215.2324.5824.475.605.605.605.605.605.60
Total Liabilities86.2849.6961.0742.5342.1929.1028.2625.4436.7036.4436.537.046.705.915.745.795.77
Retained Earnings(407.02)(383.27)(368.82)(348.00)(328.63)(293.72)(278.30)(262.32)(236.04)(222.72)(210.67)(6.07)(5.25)(4.38)(3.85)(0.37)(0.28)
Total Stockholder Equity*29.4250.9743.740.3016.8646.2244.1357.1979.6689.4499.75(6.07)(5.25)(4.38)(3.85)156.24156.33

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.090.1130.920.860.840.870.250.990.780.620.260.420.921.16------------
Cost of Revenue0.030.030.050.050.050.040.060.070.040.030.050.040.050.04------------
Gross Profit0.060.0830.870.810.790.820.200.920.730.590.220.380.341.121.05----------
Research & Development16.5915.7816.8214.0313.8513.4810.9711.6011.139.118.518.568.508.25------------
Selling, General & Admin5.836.377.297.106.266.265.905.676.475.904.186.345.324.410.850.780.910.420.060.06
Total Operating Expenses22.4222.1524.1121.1320.1219.7516.8717.2617.5915.0112.7014.901.2812.671.93----------
Operating Income(22.36)(22.08)6.75(20.31)(19.33)(18.92)(16.68)(16.34)(16.86)(14.42)(12.48)(14.52)(12.96)(11.54)(0.88)(0.81)(0.94)(0.45)(0.09)(0.09)
Interest Expense--------------------------0.35------------
Net Income(23.75)(20.69)6.25(20.83)(19.36)(18.75)(16.15)(15.43)(15.98)(13.46)(12.82)(13.32)(12.05)(10.94)(0.88)(0.69)(0.73)(0.44)(0.09)(0.09)
Basic EPS(0.38)(0.33)0.28(0.40)(0.50)(0.49)(0.42)(0.41)(0.45)(0.38)(0.35)(0.38)(0.35)(0.40)(0.06)(0.05)(0.04)(0.02)----
Diluted EPS(0.38)(0.33)0.28(0.40)(0.50)(0.49)(0.42)(0.41)(0.45)(0.38)(0.35)(0.38)(0.35)(0.40)(0.07)(0.05)(0.04)------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(19.33)(22.17)(2.27)(14.55)(15.53)(16.62)(13.54)(13.70)(10.21)(13.11)(10.97)(10.28)(10.49)(14.38)(0.56)(0.57)(0.11)(0.34)(0.03)(0.13)
Capital Expenditures0.250.180.030.310.030.110.110.070.110.01-0.000.020.030.04------------
Free Cash Flow*(19.59)(22.35)(2.30)(14.86)(15.56)(16.73)(13.64)(13.77)(10.31)(13.12)(10.97)(10.30)(10.52)(14.42)------------
Investing Cash Flow(23.31)10.32(17.71)(38.58)16.3613.00(3.75)0.5610.425.8633.1512.958.12(43.53)0.0092.59------(160.00)
Financing Cash Flow34.755.5312.6676.40(0.43)(0.30)13.9515.040.170.02(10.70)0.000.0956.820.00(92.59)------162.29

* Derived from reported values